The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Is nose-to-brain transport of drugs in man a reality?
Open accessAbstract
The blood–brain barrier that segregates the brain interstitial fluid from the circulating blood provides an efficient barrier for the diffusion of most, especially polar, drugs from the blood to receptors in the central nervous system (CNS). Hence limitations are evident in the treatment of CNS diseases, such as Parkinson's and Alzheimer's diseases, especially exploiting neuropeptides and similar polar and large molecular weight drugs. In recent years interest has been expressed in the use of the nasal route for delivery of drugs to the brain, exploiting the olfactory pathway. A wealth of studies has reported proof of nose-to-brain delivery of a range of different drugs in animal models, such as the rat. Studies in man have mostly compared the pharmacological effects (e.g. brain functions) of nasally applied drugs with parenterally applied drugs and have shown a distinct indication of direct nose-to-brain transport. Recent studies in volunteers involving cerebrospinal fluid sampling, blood sampling and pharmacokinetic analysis after nasal, and in some instances parenteral administration of different drugs, have in my opinion confirmed the likely existence of a direct pathway from nose to brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sniffing neuropeptides: A transnasal approach to the human brain
Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356
How the olfactory system makes sense of scents
Firestein, S. (2001) · Nature · doi:10.1038/35093026 · Cited by 1,263
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Self-citationThorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Human Physiology : From Cells to Systems
Sherwood, L. (1989) · Cited by 956
Extracellular space structure revealed by diffusion analysis
Nicholson, C., & Syková, E. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01261-2 · Cited by 914
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907 · cited 6×
“The various pathways that a drug can follow from the olfactory region of the nasal cavity to reach the CSF or the brain tissue have been discussed thoroughly (Mathison et al 1998; Dahlin 2000; Illum 2000; Thorne & Frey 2001), hence only a brief discussion will be given here.”
BackgroundResultInfluentialSelf-citationTight junctions and the molecular basis for regulation of paracellular permeability
Anderson, J. M., & Van Itallie, C. M. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.4.g467 · Cited by 843
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Molecular structure and assembly of the tight junction
Denker, B. M., & Nigam, S. K. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.1.f1 · Cited by 404
Quantitative analysis of the olfactory pathway for drug delivery to the brain
Thorne, R. G., Emory, C. R., Ala, T. A., & Frey, W. H. (1995) · Brain Research · doi:10.1016/0006-8993(95)00637-6 · Cited by 352
McMartin, C., Hutchinson, L. E. F., Hyde, R., & Peters, G. E. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760709 · Cited by 349
Peptide Drug Delivery to the Brain
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-783_2 · Cited by 308
Improving influence of insulin on cognitive functions in humans
Kern, W., Peters, A., Fruehwald-Schultes, B., Deininger, E., Born, J., & Fehm, H. L. (2001) · Neuroendocrinology · doi:10.1159/000054694 · Cited by 308
Taste and Smell in Vertebrates.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-5-825_2 · Cited by 283
The fine structure of the olfactory mucosa in man
Moran, D. T., Rowley, J. C., Jafek, B. W., & Lovell, M. A. (1982) · Journal of Neurocytology · doi:10.1007/bf01153516 · Cited by 281
The nose and paranasal sinuses physiology and anatomy
Jones, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00172-7 · Cited by 253
Cerebrospinal Fluid Insulin Levels Increase During Intravenous Insulin Infusions in Man*
WALLUM, B. J., TABORSKY, G. J., PORTE, D., FIGLEWICZ, D. P., JACOBSON, L., BEARD, J. C., WARD, W. K., & DORSA, D. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-190 · Cited by 253
Delivery of Nerve Growth Factor to the Brain via the Olfactory Pathway
Chen, X.-Q., Fawcett, J. R., Rahman, Y.-E., Ala, T. A., & Frey II, W. H. (1998) · Journal of Alzheimer's Disease · doi:10.3233/jad-1998-1102 · Cited by 247
Brain Drug Targeting: The Future of Brain Drug Development
Pardridge, W. M. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511549571 · Cited by 246
Research advances in Alzheimer's disease and related disorders
Iqbal, K., & Disorders, R. (1995) · Wiley eBooks · Cited by 228
Enhancing paracellular permeability by modulating epithelial tight junctions
Ward, P. D., Tippin, T. K., & Thakker, D. R. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00302-3 · Cited by 227
Shipley, M. T. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90129-7 · Cited by 209
Morphology of olfactory epithelium in humans and other vertebrates
Morrison, E. E., & Costanzo, R. M. (1992) · Microscopy Research and Technique · doi:10.1002/jemt.1070230105 · Cited by 204
Nasal Route for Direct Delivery of Solutes to the Central Nervous System: Fact or Fiction?
Mathison, S., Nagilla, R., & Kompella, U. B. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997870 · Cited by 200
Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins
Tsukamoto, T., & Nigam, S. K. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f737 · Cited by 195
Central nervous system effects of intranasally administered insulin during euglycemia in men.
Kern, W., Born, J., Schreiber, H., & Fehm, H. L. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192
Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid.
Schwartz, M. W., Sipols, A., Kahn, S. E., Lattemann, D. F., Taborsky, G. J., Bergman, R. N., Woods, S. C., & Porte, D. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.3.e378 · Cited by 191
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Gozes, I., Bardea, A., Reshef, A., Zamostiano, R., Zhukovsky, S., Rubinraut, S., Fridkin, M., & Brenneman, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.427 · Cited by 181
The epithelial tight junction: Structure, function and preliminary biochemical characterization
Stevenson, B., Anderson, J., & Bullivant, S. (1988) · Molecular and Cellular Biochemistry · doi:10.1007/bf00226141 · Cited by 175
The upper airways. I. Nasal physiology and defense of the lungs.
Proctor, D. F. (1977) · PubMed · doi:10.1164/arrd.1977.115.1.97 · Cited by 161
Sherry Chow, H. ‐., Chen, Z., & Matsuura, G. T. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9900295 · Cited by 161
UPTAKE OF ALUMINIUM INTO CENTRAL NERVOUS SYSTEM ALONG NASAL-OLFACTORY PATHWAYS
Perl, D., & Good, P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92288-4 · Cited by 159
The Olfactory Neuron and the Blood-Brain Barrier
de Lorenzo, A. J. D. (2008) · Novartis Foundation symposium · doi:10.1002/9780470715369.ch9 · Cited by 152
Brain Drug Targeting: The Future of Brain Drug Development
Pardridge, W. M. (2001) · Cited by 150
Baker, H. A., & Spencer, R. F. (1986) · Experimental Brain Research · doi:10.1007/bf00237470 · Cited by 149
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4-10 Decreases Body Fat in Humans
Fehm, H. L., Smolnik, R., Kern, W., McGregor, G. P., Bickel, U., & Jan Born, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7298 · Cited by 144
Subarachnoid Space of the CNS, Nasal Mucosa, and Lymphatic System
Jackson, R. T., Tigges, J., & Arnold, W. J. (1979) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1979.00790160014003 · Cited by 143
Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity
Sakane, T., Akizuki, M., Yoshida, M., Yamashita, S., NADAI, T., Hashida, M., & Sezaki, H. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03510.x · Cited by 143
Pietrowsky, R., Strüben, C., Mölle, M., Fehm, H. L., & Born, J. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00180-8 · Cited by 141
Uptake of exogenous proteins in mouse olfactory cells
Kristensson, K., & Olsson, Y. (1971) · Acta Neuropathologica · doi:10.1007/bf00688493 · Cited by 121
Wang, F., Jiang, X., & Lu, W. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00341-7 · Cited by 120
Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier
Minn, A., Leclerc, S., Heydel, J., Minn, A.-L., Denizot, C., Cattarelli, M., Netter, P., & Grădinaru, D. (2002) · Journal of drug targeting · doi:10.1080/713714452 · Cited by 106
Nasal Delivery. The Use of Animal Models to Predict Performance in Man
Illum, L. (1996) · Journal of drug targeting · doi:10.3109/10611869609015963 · Cited by 101
Self-citationTransfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice
Dahlin, M., Bergman, U., Jansson, B., Björk, E., & Brittebo, E. B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007542618378 · Cited by 100
Levels of dopamine in blood and brain following nasal administration to rats
Dahlin, M., Jansson, B., & Björk, E. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00151-8 · Cited by 97
Pietrowsky, R., Thiemann, A., Kern, W., Fehm, H. L., & Jan Born, A. (1996) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(96)00012-1 · Cited by 86
Anterograde transsynaptic transport of WGA-HRP in rat olfactory pathways
Itaya, S. K. (1987) · Brain Research · doi:10.1016/0006-8993(87)90703-7 · Cited by 85
Ang, V. T. Y., & Jenkins, J. S. (1982) · Journal of Endocrinology · doi:10.1677/joe.0.0930319 · Cited by 84
Perras, B., Marshall, L., Köhler, G., Jan Born, A., & Fehm, H. L. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00027-x · Cited by 82
P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation
Graff, C. L., & Pollack, G. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1025053115583 · Cited by 81
Direct access of drugs to the human brain after intranasal drug administration?
Merkus, P., Guchelaar, H.-J., Bosch, D. A., & Merkus, F. W. H. M. (2003) · Neurology · doi:10.1212/01.wnl.0000067993.60735.77 · Cited by 81
The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4-10 Decreases Body Fat in Humans
Fehm, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1144 · Cited by 74
Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology?
Fehm, H. L., Perras, B., Smolnik, R., Kern, W., & Jan Born, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00540-9 · Cited by 69
Ohtake, K., Maeno, T., UEDA, H. M. D., Ogihara, M., Natsume, H., & Morimoto, Y. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003383.86238.d1 · Cited by 67
Nasal Absorption of Zidovudine and Its Transport to Cerebrospinal Fluid in Rats.
Seki, T., Sato, N., Hasegawa, T., Kawaguchi, T., & Juni, K. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.1135 · Cited by 63
Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat
Wang, Y., Aun, R. L., & Tse, F. L. S. (1998) · Biopharmaceutics & Drug Disposition · Cited by 62
Direct Nose–Brain Transport of Benzoylecgonine Following Intranasal Administration in Rats
Chow, H. ‐. S., Anavy, N. D., & Villalobos, A. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1122 · Cited by 57
Nasal absorption of hydroxocobalamin in healthy elderly adults
van Asselt, D. Z. B., Merkus, F. W. H. M., Rüssel, F. G. M., & Hoefnagels, W. H. L. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00642.x · Cited by 48
Beneficial Treatment of Age-Related Sleep Disturbances With Prolonged Intranasal Vasopressin
Perras, B., Pannenborg, H., Marshall, L., Pietrowsky, R., Born, J., & Fehm, H. L. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00007 · Cited by 46
Intranasal angiotensin II directly influences central nervous regulation of blood pressure
Derad, I., Willeke, K., Pietrowsky, R., Jan Born, A., & Fehm, H. L. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00095-8 · Cited by 43
Lindhardt, K., Gizurarson, S. S., Stefánsson, S. B., Òlafsson, D. R., & Bechgaard, E. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01486.x · Cited by 39
Chou, K.-J., & Donovan, M. D. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00170-7 · Cited by 34
Smolnik, R., Mölle, M., Fehm, H. L., & Jan Born, A. (1999) · Neuroendocrinology · doi:10.1159/000054460 · Cited by 33
The first attempt at radioisotopic evaluation of the integrity of the nose-brain barrier
Okuyama, S. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00149-5 · Cited by 32
Kern, W., Schiefer, B., Schwarzenburg, J., Stange, E. F., Jan Born, A., & Fehm, H. L. (2008) · Neuroendocrinology · doi:10.1159/000127187 · Cited by 31
Peptide Drug Delivery to the Brain
Rapoport, S. I. (1992) · Neurology · doi:10.1212/wnl.42.5.1131-c · Cited by 31
Nasal Delivery of [14C]Dextromethorphan Hydrochloride in Rats: Levels in Plasma and Brain
Charx, H., Kumar, S., Patel, S. B., Piemontese, D., Iqbal, K., Malick, A. W., Salvador, R. A., & Behl, C. R. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810806 · Cited by 29
The effect of GRF on the EEG sleep of normal males.
Dj, K., Db, J., & Ehlers, C. (1991) · PubMed · Cited by 26
Smolnik, R., Perras, B., Mölle, M., Fehm, H. L., & Jan Born, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00009 · Cited by 25
Circulating neuroactive peptides and the blood-brain and blood-cerebrospinal fluid barriers.
Zloković, B. V., Mb, S., Davson, H., Lipovac, M. N., Hyman, S., & McComb, J. G. (1990) · PubMed · Cited by 25
Time Course of Intranasally Administered Cholecystokinin-8 on Central Nervous Effects
Pietrowsky, R., Claassen, L., Frercks, H., Fehm, H. L., & Born, J. (2001) · Neuropsychobiology · doi:10.1159/000054899 · Cited by 22
GM1 Delivery to the CSF Via the Olfactory Pathway
Kumbale, R., Frey, W. H., Wilson, S., & Rahman, Y. E. (1999) · Drug Delivery · doi:10.1080/107175499267129 · Cited by 16
Selective delivery of insulin into the brain: Intraolfactory absorption
Gizurarson, S. S., Thorvaldsson, T., Sigurdsson, P., & Gunnarsson, E. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04579-6 · Cited by 14
Applied Anatomy and Physiology of Nose
Wei, X., & Bi, X. (2021) · Springer eBooks · doi:10.1007/978-981-13-7993-2_9 · Cited by 13
Engström, B., Ekblom, A., & Hansson, P. T. (1989) · Acta Oto-Laryngologica · doi:10.3109/00016488909125526 · Cited by 12
Cited by
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734
Self-citationThe Adverse Effects of Air Pollution on the Nervous System
Genc, S., Zadeoglulari, Z., Fuss, S. H., & Genc, K. (2012) · Journal of Toxicology · doi:10.1155/2012/782462 · Cited by 717
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Metadata
- Authors
- Illum, L.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-01
- Volume
- 56
- Issue
- 1
- Pages
- 3-17
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2083588057
- Cited by
- 439
- References
- 76
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.